CVS acquires at-home health care company: How it could impact medical services

CVS Health Corp announced Monday it would be closing its acquisition of home health care services company Signify Health.

The deal, which was originally agreed upon in September 2022, allows retail pharmacy chain to acquire Signify for $30.50 per share for a total value of approximately $8 billion.

“We have nothing additional to share at this time; we’ll of course have more to say upon expected closure of the deal,” a spokesperson for CVS told ABC News.

By buying Signify, CVS will be among the first pharmacy chains in the U.S. to enter the at-home health care space after building its successful Minute Clinics.

Signify Health has thousands of employees including physicians, nurse practitioners and other clinicians which provide a “holistic suite of clinical, social, and behavioral services to address an individual’s healthcare needs and prevent adverse events that drive excess cost, all while shifting services towards the home,” the company said in a press release.

Here’s how the deal may affect services including COVID testing and abortion care.

COVID tests performed at home

While every American has been able to either buy at rapid at-home antigen tests at their local store or get them delivered to their doors, polymerase chain reaction (PCR) tests have been reserved for doctors’ offices, clinics and pharmacies.

CVS acquires at-home health care company: How it could impact medical services

A test swab at a CDC Covid-19 variant testing site inside Tom Bradley International Terminal at Los Angeles International Airport (LAX) in Los Angeles, Jan. 9, 2023.

Bloomberg via Getty Images, FILE

PCR tests, which look for genetic material from the virus, are considered the “gold standard” when it comes to COVID-19 testing.

While less accurate than PCR tests, antigen tests are still considered quite accurate when used in people with symptoms of infection. The tests look for proteins on the surface of the virus and can deliver results in 15 minutes or less.

CVS has been offering PCR testing at its stores but, with Signify already having a system in place providing on-site COVID screening, clinicians may be able to perform such testing in people’s homes.

Abortion services

It’s not clear how the CVS acquisition will affect abortion pills, but at-home care could be provided.

In January, after a change in rules from the U.S. Food and Drug Administration, both CVS and Walgreens announced plans to seek certification to distribute abortion pills where legally allowed.

Despite Walgreens saying it would not distribute mifepristone in 21 states after conservative attorneys general threatened legal action, CVS has not said it will be doing the same.

Even if CVS does follow in Walgreens’ footsteps, licensed physicians may be able to prescribe pills directly in a woman’s home in states where procedure is legal,.

Signify Health declined to comment to ABC News.

Expanding health care into rural areas

According to the American Hospital Association, there are just 1,805 rural hospitals in the U.S., the latest date for which data is available. It also represents a 59{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} decrease since 2019.

PHOTO: FILE - A CVS location in New York, Feb. 9, 2023.

A CVS location in New York, Feb. 9, 2023.

Bloomberg via Getty Images, FILE

What’s more, a January report from the Center for Healthcare Quality and Payment Reform found that 631 rural hospitals — or roughly 30{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} — are at immediate risk or high risk of closing due to low financial reserves or being too dependent on certain forms of revenue such as state subsidies.

By comparison, CVS has more than 9,000 stores across the country.

The acquisition may allow the company to be able to reach traditionally underserved communities that live far away from metropolitan areas.

Medical Manufacturing Technologies (MMT) Acquires Confluent Medical Equipment Line

CHARLOTTE, N.C., Nov. 2, 2022 /PRNewswire/ — Professional medical Production Technologies (MMT), a portfolio company of Arcline Investment decision Management and a top worldwide service provider of clinical device manufacturing remedies, declared the obtain of Confluent Health-related Technologies’ devices manufacturing team, which includes their balloon forming machines manufacturing as very well as their testing and catheter manufacturing equipment capabilities. These will be rebranded as Interface Catheter Remedies (Interface), a return to its historic roots.

“The acquisition of the renowned Interface Catheter Remedies devices line is a strategic investment decision that expands our potential to meet up with the escalating desires of our customers,” explained Robbie Atkinson, CEO of MMT. “Globally regarded as the benchmark balloon catheter gear system, the Interface manufacturer, and its dedicated group even more fortify our close-to-stop catheter machines producing portfolio.”

“MMT is the great steward for the Interface brand name,” mentioned Dean Schauer, CEO of Confluent. “Confluent is psyched to carry on to grow our marriage with the MMT workforce. This deal permits Confluent to aim our power on our Elements Science capabilities for production of Nitinol Parts, Textiles, Balloons, Balloon Catheters, Polymer Parts, and completely, finished units using these abilities.”

MMT will assist the Interface Catheter Remedies legacy through ongoing merchandise innovation, thoughtful integration in just its products line, and reinforcing its placement as a international leader in the industry. As section of the acquisition, MMT will continue on production Interface answers at the Laguna Niguel, CA facility.

“The cardiovascular and neurovascular health care unit marketplaces demand from customers good quality and excellence alongside just about every step of advancement. Life depend on it,” said Atkinson. “The Interface brand is identified globally for its high-quality, precision, and repeatability. It is our honor to convey this perfectly-respected brand name into our developing portfolio.”

As a leading service provider of high-precision manufacturing answers for intricate health care devices, MMT gives its shoppers a broad portfolio of technologies used to produce minimally invasive health care equipment for lifestyle-saving treatments. Its robust giving expands past gear and systems to evidence-of-idea, system enhancement, and TotalCare aftermarket guidance and services. 

ABOUT MMT  

Clinical Manufacturing Technologies (MMT) is a vertically built-in business enterprise serving the clinical product production industry and beyond. The firm delivers approach growth, apps and equipment, complex answers, and aftermarket help. MMT brands include CATHTIP, Engineering By Style, Glebar, Interface Catheter Methods, MPT Europe, R&D Engineering, SYNEO, and Tridex.

Resource Health-related Manufacturing Technologies (MMT)